Diagnosis and staging
PET-CT vs Biopsy: — Which Test Actually Diagnoses Cancer?
A PET-CT scan and a biopsy answer different questions. One maps where unusual activity is happening in your body. The other looks at cells under a microscope and tells you what they are. Only one of them can diagnose cancer.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026
- PET shows activity, not cells — A PET-CT highlights where metabolism is high, but cannot tell whether those cells are cancerous.
- Only a biopsy confirms — A pathologist examining tissue under a microscope is the only way to confirm a cancer diagnosis.
- They answer different questions — PET-CT maps spread. Biopsy identifies what the cancer is. Both are usually needed, at different points.
- Order matters — In most situations biopsy comes first to confirm the diagnosis, and PET-CT follows to map how far it has spread.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
A PET-CT scan cannot diagnose cancer. It shows where cells in your body are unusually active — which can indicate cancer — but a biopsy, where tissue is examined under a microscope, is the only test that confirms it. In most cases, doctors order the biopsy first, then use PET-CT to see how far the cancer has spread.
A whole-body PET-CT at CION costs from Rs 10,499 — among the lowest published prices in Hyderabad. Indicative price, as of September 2026.
How is a PET-CT scan different from a biopsy?
| Feature | PET-CT scan | Biopsy |
|---|---|---|
| What it does | Maps metabolic activity across the body using a radioactive tracer | Removes a small tissue sample and examines it under a microscope |
| Can it confirm cancer? | No | Yes — it is the only test that can |
| What it shows | Where cells are unusually active | Whether cells are cancerous, what type, and how aggressive they are |
| What it cannot show | Whether active areas are cancer, infection, or inflammation | How far cancer has spread to other organs |
| When typically ordered | After biopsy confirms cancer, to map spread; or before biopsy to find the right site | When cancer is first suspected, to confirm the diagnosis |
| Result turnaround | Usually same day or next | Pathology typically takes several days to two weeks |
| What it informs | Staging and treatment planning | Diagnosis, cancer type, grade, and biomarker status for targeted therapy |
When do you still need a biopsy?
- Cancer has not yet been confirmed — a scan alone is never enough to start treatment
- The cancer type or grade affects which treatment is planned
- Biomarker testing is needed to check eligibility for immunotherapy or targeted therapy
- A scan shows something suspicious that could be cancer, infection, or inflammation
- Cancer has returned and a new tissue sample is needed to guide the next treatment
What do these words mean?
- PET-CT
- A scan combining positron emission tomography with CT. A radioactive tracer is injected, and the scanner shows where it concentrates — usually where cells are most metabolically active. At CION, PET-CT is coordinated with partner imaging centres.
- Biopsy
- A procedure where a small sample of tissue is removed from a suspicious area and examined by a pathologist under a microscope. The pathology report is the document that formally confirms whether cancer is present.
- Staging
- The process of establishing how far cancer has spread in the body. PET-CT is one of the main tools used for staging, after a biopsy has confirmed cancer.
- False positive
- When a test suggests cancer is present when it is not. PET-CT can show increased activity in infections, TB, healing tissue, and inflammatory conditions — all common in India.
- Pathology
- The laboratory science of examining tissue samples. It determines not only whether cancer is present but also its type, grade, and molecular characteristics.
PET-CT Partner Centres
PET-CT Scan Centres in Hyderabad
CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.
PET-CT Centre — Punjagutta
PET-CT Centre — Himayatnagar
PET-CT Centre — Narayanaguda
These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Know the cost before you commit
An itemised estimate, plus a check of which schemes you may qualify for.
Why can a PET-CT not diagnose cancer?
A PET-CT measures metabolic activity — how much energy cells are consuming — but it cannot identify what kind of cells they are. Cancer cells are usually highly active, so they show up brightly on the scan. But so do many other conditions.
Tuberculosis, sarcoidosis, recent surgery, and inflammatory conditions all produce the same kind of signal. In India, where TB is common, a bright area on a PET-CT can look identical to a cancer deposit.
Only a pathologist examining cells under a microscope can tell whether they are cancerous. A scan, however detailed, cannot do that.
Why does tissue matter even when a scan looks worrying?
The type of cancer cell determines the entire treatment plan. Two patients with a lung mass may have completely different cancers — one responding to targeted therapy, the other not — and only tissue analysis reveals which.
Biomarker testing, which guides immunotherapy and targeted therapy eligibility, is performed on tissue from the biopsy. A scan cannot provide this information.
NCCN and ESMO guidelines consistently require histological confirmation — tissue evidence of cancer — before treatment begins. This is not a procedural formality. It is what ensures the right treatment is given.
Which comes first — the scan or the biopsy?
In most situations, biopsy comes first. Once a cancer diagnosis is confirmed, a PET-CT is used to stage the disease — to see whether it has spread, and to inform the treatment plan.
There are exceptions. When the primary tumour cannot be found, a PET-CT may be ordered first to locate it so the biopsy targets the right place. When multiple suspicious areas are visible, a PET-CT helps the team choose which one is most likely to give a useful sample.
PET-CT and biopsy are not competing tests. They work in sequence, each answering a question the other cannot.
PET-CT at CION starts from Rs 10,499 — among the lowest published prices in Hyderabad — across 4 partner centres in Banjara Hills, Punjagutta, Himayatnagar and Narayanaguda. Indicative price, as of September 2026.
Explore 30 more Specialised Tracers and How PET-CT Compares topics
PET-CT vs Other Scans
- Can an MRI Replace a PET-CT to Avoid Radiation?
- Choosing Between Scans: A Decision Guide by Question
- Combining PET-CT With MRI in the Same Week
- Diagnostic CT vs the CT Inside a PET-CT
- Do You Need Both a CT and a PET-CT?
- Follow-Up Scanning: Alternating PET With Other Tests
- PET-CT vs Biopsy: Which Actually Diagnoses Cancer?
- PET-CT vs Bone Scan for Bone Metastases
- PET-CT vs CT Scan: What Is the Difference?
- PET-CT vs MRI: Which Do You Need?
- PET-CT vs PET-MRI: Is the Newer Machine Better?
- PET-CT vs Tumour Markers for Follow-Up
- PET-CT vs Ultrasound and Mammography
- PET-CT vs Whole-Body MRI for Screening
- When Is a PET-CT Not the Right Test?
- Why Your Doctor Ordered PET-CT and Not a Cheaper Scan
Timing Around Treatment
- Baseline PET-CT Before Starting Treatment: Why It Matters
- Can a PET-CT Be Done During Active Chemotherapy?
- Emergency and Urgent PET-CT: When It Cannot Wait
- How Soon After a Previous PET Can You Have Another?
- Interim vs End-of-Treatment Scanning
- PET-CT After Growth Factor Injections
- PET-CT After Steroids: Does It Affect the Scan?
- PET-CT After a Biopsy: How Long to Wait
- PET-CT Before Surgery: What Surgeons Want to Know
- Scanning Too Early: Why It Wastes Money and Causes Panic
- When Should You Have a PET-CT After Chemotherapy?
- When Should You Have a PET-CT After Immunotherapy?
- When Should You Have a PET-CT After Radiotherapy?
- When Should You Have a PET-CT After Surgery?
Your next step
Talk to an oncologist about your scan
Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.
Common questions
Frequently asked questions
My PET-CT showed a suspicious area. Does that mean I have cancer?
Not necessarily. A bright area on a PET-CT means cells there are metabolically active, and cancer is one reason that happens — but so are infections, inflammation, tuberculosis, healing after surgery, and several other conditions. Your doctor will use the PET-CT finding to decide where to take a biopsy, and the biopsy is what will tell you whether cancer is present. Until that result comes back, a scan finding is a question, not a diagnosis.
Can a PET-CT miss cancer?
Yes. PET-CT is sensitive for many cancers but not all. Small deposits, some slow-growing tumours, and certain cancer types do not show strong metabolic activity and may not appear clearly on the scan. A normal PET-CT does not rule out cancer if other clinical findings suggest it is present. Your oncologist will interpret the scan alongside your symptoms, blood tests, and any other investigations rather than relying on the scan result alone.
Can a biopsy be wrong?
A biopsy gives an accurate result for the tissue sampled, but the sample may not always represent the whole tumour — particularly in large or varied cancers. If the result does not fit the clinical picture, your oncologist may recommend a repeat biopsy from a different site or a larger sample. Pathology is reported by a specialist, and in complex cases a second opinion from another pathologist is a reasonable request.
Why did my doctor order a PET-CT before doing a biopsy?
This happens when the primary tumour has not been found and the scan is needed to locate it, when there are multiple suspicious areas and the team must decide which one to biopsy, or when the PET-CT is needed to plan a procedure. It does not mean the biopsy has been skipped — it means the scan is being used to make the biopsy more accurate. A tissue diagnosis is still needed before treatment begins.
Do I need another biopsy if my cancer comes back?
Often, yes. Tumours can change their molecular characteristics between the original diagnosis and a recurrence, and a treatment that was right the first time may not be the best choice again. A repeat biopsy allows biomarker testing on the current disease, which can open up treatment options — including immunotherapy or targeted therapy — that were not available before. Your oncologist will advise whether this applies in your situation.
What if a biopsy is too risky — can PET-CT be used to diagnose instead?
There are rare situations where biopsy carries too high a risk and treatment decisions must be made on clinical and imaging grounds alone. This is an exception, and it is a judgement made by your oncologist based on the specific risks in your case. Where tissue can be obtained safely — even from a less accessible site — that is always preferred. Your team will explain the reasoning if a biopsy has been assessed as too risky for your situation.